These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12377637)

  • 1. Good news for South African AIDS patients.
    Ann Oncol; 2002 Oct; 13(10):1513. PubMed ID: 12377637
    [No Abstract]   [Full Text] [Related]  

  • 2. AIDS activists fail to block 'reasonable pricing' reform.
    Gavaghan H
    Nature; 1995 Jan; 373(6512):272. PubMed ID: 7830751
    [No Abstract]   [Full Text] [Related]  

  • 3. Business and AIDS: sectoral challenges and opportunities.
    Weston MD; Churchyard GJ; Mametja D; McIntyre JA; Randera F
    AIDS; 2007 Jul; 21 Suppl 3():S85-9. PubMed ID: 17666966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral therapy cannot be South Africa's first priority.
    Ncayiyana DJ
    CMAJ; 2001 Jun; 164(13):1857-8. PubMed ID: 11450284
    [No Abstract]   [Full Text] [Related]  

  • 5. No money, no meds.
    Mabry M
    Newsweek; 1999 Jul; 134(2):32-3. PubMed ID: 10538648
    [No Abstract]   [Full Text] [Related]  

  • 6. International expenditure projections for pharmacotherapeutic advances in the treatment of HIV/AIDS.
    Sclar DA; Robison LM; Skaer TL; Terriff CM; Garrison MW
    Clin Ther; 1997; 19(1):86-95; discussion 84-5. PubMed ID: 9083711
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost effectiveness and AIDS: science or marketing? Proceedings of a workshop. Washington, D.C., January 28, 1995.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 4():S1-32. PubMed ID: 7493191
    [No Abstract]   [Full Text] [Related]  

  • 8. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
    Curti AM
    Am J Law Med; 2001; 27(4):469-85. PubMed ID: 11837145
    [No Abstract]   [Full Text] [Related]  

  • 9. AIDS and the private sector.
    Nature; 2006 Oct; 443(7113):723. PubMed ID: 17051166
    [No Abstract]   [Full Text] [Related]  

  • 10. Twenty-five years of AIDS.
    Cameron DW
    CMAJ; 2006 Aug; 175(3):225, 227. PubMed ID: 16880433
    [No Abstract]   [Full Text] [Related]  

  • 11. [How to balance the antiretrovirus drugs and cost in China].
    Li TS
    Zhonghua Yi Xue Za Zhi; 2012 May; 92(17):1153-4. PubMed ID: 22882999
    [No Abstract]   [Full Text] [Related]  

  • 12. GSK and Boehringer agree to generic AIDS drugs deal.
    Nelson K
    Lancet; 2003 Dec; 362(9401):2074. PubMed ID: 14700066
    [No Abstract]   [Full Text] [Related]  

  • 13. AIDS myths that need eradicating.
    Nature; 1996 Jul; 382(6589):283. PubMed ID: 8684445
    [No Abstract]   [Full Text] [Related]  

  • 14. The costing of HIV/AIDS--without a clue?
    van der Linde I
    S Afr Med J; 1999 Jan; 89(1):33-4. PubMed ID: 10070404
    [No Abstract]   [Full Text] [Related]  

  • 15. Call for HIV therapy cash.
    Ward P
    Nurs Times; 1995 Nov 15-21; 91(46):8. PubMed ID: 8552488
    [No Abstract]   [Full Text] [Related]  

  • 16. S Africa shifts AIDS drug stance for rape victims.
    Baleta A
    Lancet; 2002 Apr; 359(9316):1498. PubMed ID: 11988260
    [No Abstract]   [Full Text] [Related]  

  • 17. Ethics and AIDS drugs.
    Dowell W
    Time; 1999 Jul; 154(2):49. PubMed ID: 10538646
    [No Abstract]   [Full Text] [Related]  

  • 18. Opening an electronic pharmacy to the world.
    Steele FR
    Nat Med; 1996 Oct; 2(10):1064. PubMed ID: 8837594
    [No Abstract]   [Full Text] [Related]  

  • 19. The ethics of AIDS care.
    Harvey JC
    J Int Assoc Physicians AIDS Care; 1997 Nov; 3(11):14-24. PubMed ID: 11364809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV/AIDS issues take centre-stage at World Health Assembly.
    Kapp C
    Lancet; 2000 May; 355(9218):1894. PubMed ID: 10866457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.